Medline Makes Personnel Appointments

Medline, a global leader in healthcare solutions, has announced a series of strategic leadership changes aimed at strengthening its position in the healthcare industry. These changes include the retirement of Jim Pigott, the current President and Chief Operating Officer (COO), at the end of 2025, as well as the promotions of Amanda Laabs and Steve Miller to key executive roles. These transitions reflect Medline’s commitment to maintaining its leadership in the healthcare sector while ensuring a seamless evolution of its leadership team.

Jim Pigott’s Legacy and Transition

Jim Pigott, who has been a cornerstone of Medline’s success, will retire from the company at the end of 2025 after a distinguished career. Pigott has played a pivotal role in driving Medline’s growth and expanding its impact across the healthcare industry. Under his leadership, Medline has achieved remarkable milestones, including consistent sales growth and the development of innovative healthcare solutions that address the evolving needs of patients and providers.

“Jim Pigott has been instrumental to our success as a company, and his leadership has helped Medline accelerate its growth and expand its impact in meaningful ways,” said Jim Boyle, CEO of Medline. “We are appreciative of Jim staying on through the transition next year, and we wish him all the best in the next chapter.”

Pigott’s retirement marks the end of an era, but his contributions will continue to shape Medline’s future. His dedication to excellence and his ability to navigate complex challenges have left an indelible mark on the company and the broader healthcare industry.

Promotions of Amanda Laabs and Steve Miller

As part of the leadership transition, Medline has promoted two seasoned executives to key roles. Amanda Laabs, currently Executive Vice President (EVP) of Medline Brand, will assume the position of Chief Product Officer, effective January 1, 2025. In this role, Laabs will oversee the development and execution of Medline’s product strategy, ensuring that the company continues to deliver innovative and high-quality healthcare solutions to its customers.

Steve Miller, currently EVP of Supply Chain, will be promoted to the role of Chief Operating Officer (COO), also effective January 1, 2025. Miller’s extensive experience in supply chain management will be critical as Medline continues to enhance its operational efficiency and resilience in an increasingly complex healthcare landscape.

“Amanda and Steve are the absolute right choice to help lead Medline into the future,” said Boyle. “They both bring a wealth of knowledge, an entrepreneurial spirit, and a steady hand to leadership – and most importantly, a keen focus on the customer and a commitment to developing a world-class team here at Medline.”

Medline’s Impact on the Healthcare Industry

Founded in 1966, Medline has grown into a global healthcare powerhouse, achieving 58 years of consecutive sales growth. With over 43,000 employees worldwide and annual sales exceeding $23 billion, Medline is a leading provider of medical-surgical products and supply chain solutions. The company serves the entire continuum of care, from hospitals and clinics to long-term care facilities and home healthcare providers.

Medline’s success is rooted in its unique ability to combine world-class products, supply chain resilience, and clinical practice expertise. By delivering improved clinical, financial, and operational outcomes, Medline helps healthcare providers run more efficiently and effectively. The company’s commitment to innovation and customer-centric solutions has made it a trusted partner in the healthcare industry.

Looking Ahead: Medline’s Vision for the Future

As Medline prepares for these leadership changes, the company remains focused on its mission to make healthcare run better. The promotions of Laabs and Miller underscore Medline’s commitment to fostering internal talent and ensuring a smooth transition as it continues to innovate and grow.

Laabs’ appointment as Chief Product Officer highlights Medline’s emphasis on product innovation and customer satisfaction. Her deep understanding of the healthcare market and her ability to anticipate customer needs will be invaluable as Medline develops new solutions to address emerging challenges in healthcare.

Miller’s promotion to COO reflects Medline’s dedication to operational excellence and supply chain resilience. In an era where supply chain disruptions can have far-reaching consequences, Miller’s leadership will be critical in ensuring that Medline remains a reliable partner for healthcare providers worldwide.